Company Filing History:
Years Active: 2017
Title: Mette Grønborg: Innovator in Neurotherapeutics
Introduction
Mette Grønborg is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of neurotherapeutics, particularly through her innovative work on growth factors. Her research focuses on the therapeutic use of proteins, genes, and cells, aiming to address disorders of the nervous system.
Latest Patents
Mette Grønborg holds one patent titled "Therapeutic use of a growth factor, NsG33." This invention relates to the biological function of the secreted therapeutic protein NsG33, which serves as a nerve survival and growth factor. The patent highlights the antiapoptotic effects of NsG33 on neuronal potential cell lines, as well as its neuroprotective and neurogenesis effects on neural precursor cell lines and primary striatal cultures. Additionally, the invention includes novel bioactive NsG33 polypeptide fragments and their corresponding encoding DNA sequences.
Career Highlights
Mette Grønborg is associated with Hoba Therapeutics Aps, where she continues to advance her research in neurotherapeutics. Her work has garnered attention for its potential applications in treating various neurological disorders.
Collaborations
Mette collaborates with notable colleagues, including Philip Kusk and Nikolaj Blom, who contribute to her research endeavors and the development of innovative therapeutic solutions.
Conclusion
Mette Grønborg is a trailblazer in the field of neurotherapeutics, with her patent on NsG33 showcasing her commitment to advancing medical science. Her contributions have the potential to significantly impact the treatment of nervous system disorders.